The following is an anecdotal performance report from an academic series of case studies of the Aspen Laser Apex Model Exploring the science of photobiomodulation therapy (PBMT). Reports collected were from May 4-July 7, 2023 under the medical supervision of BARD DIAGNOSTIC IMAGING. Quantitative imaging reports in this review were conducted strictly with the use of 3D Doppler Ultrasound imaging and Elastographic technology and are submitted by Dr. Robert L. Bard.
CASE STUDY #1: EDEMA / L HAND
5-23-2023 1:53:23pm
PATIENT NARRATIVE: Around 5-9, I fell down a flight of stairs and landed on my hands causing major bruising and significant inflamed swelling on both. I used ice on it frequently + 600mg ibuprofen and counted on nature to make it go away.
On 5/23, I experienced a 15 minute demo treatment of the (Aspen) laser on my left hand only. I would say like right away I noticed a difference. I had more flexibility in my wrist right away. It just continued to get better and better (from the treatment). I was able to sleep through the first night without any pain when I rolled over on my hand. The next day, the purple began to fade and it started to turn yellow- indicating recovery. The other hand (untreated) was still purple. It was interesting to see the comparison and that the hand that was treated was the worst hand. I could see the recovery on the spot! And by the second or third day, it was completely gone- and the other hand was still purple. As an athlete, I'm no stranger to bruises and bumps from things like falling off a bicycle. My one experience with this laser therapy was the fastest recovery...I would say by double, if not triple, because the purple started going away right away.
CASE STUDY #7: DERMAL EDEMA
INITIAL NOTES from 6/21: Lymphedema in the right arm from breast cancer surgery. The patient expressed that lymph node was not painful, but that the arm felt heavy. A scan from the elbow down to the wrist indicated massive subcutaneous edema. Epidermal thickening from 0.2 millimeters to 0.9 millimeters, epidermal thickening, dermal edema from 1mm to 2mm, and the subcutaneous tissue was bulging and firm and expanded to 12mm when the normal side was three millimeters. Patient expressed improvement upon 1 (20 min) treatment/exposure to PBM light therapy. The ultrasound imaging shows dark edematous thickening of the epidermis to three millimeters, and the elastography confirms the mean of three kpa demonstrating that this is edematous fluid. Adjacent to the edema is a scar which shows up at 4.6 kpa showing that it's harder tissue than the edema.
PHYSICIAN’S NOTES: The importance of elastography in imaging edematous tissue is to find out where the inflammatory edema or backup edema is causing a permanent fibrotic or scarring process. The last study demonstrates that fibrosis or scar formation is now beginning in the tissues of the leg. So medical attention has to be paid to this to reduce the edema that will result in scarification and fibrosis of a permanent nature.
THE PBM DEVICE UNDER REVIEW / ASSESSMENT & INITIAL STUDIES
It is reported that the mitochondrial respiratory chain is a suitable chromophore for red to near-infrared light. It can be concluded that mitochondria are appropriate targets in laser therapy (photobiomodulation therapy). It is a well-known fact that mitochondria are the important organelles of the cells which contain critical biomolecules such as reactive oxygen species (ROS), nitric oxide (NO), adenosine triphosphate (ATP), and cyclic adenosine monophosphate (cAMP). It is proposed that laser therapy affects the production of these biomolecules, which is accompanied by the initiation of cell proliferation. This, in turn, induces the signal cascade effects. Recently, researchers have published findings of the role of LLLT in the prevention of endothelial dysfunction development in COVID-19 patients. Based on these investigations, the clinical experience of the treatment and rehabilitation of COVID-19 patients is affected by LLLT. [1]
APEX NEAR INFRARED THERAPY: Upon review of the company’s information: the Apex Laser series is the world’s first and only laser device of its kind, the Apex Tri-Wave Laser Series is changing the way health care professionals are treating pain and injuries. Uniquely featuring three wavelengths of 810nm, 980nm and 1064nm, the Apex Tri-Wave incorporates 15 watts of high power with each wavelength for a combined total output of 45 watts. Their TRI-WAVE technology capacitates 810nm, 980nm and 1064nm wavelength. The Aspen Laser can deliver more energy than other therapy lasers. More power equates to deeper penetration, faster treatment times and delivery of the proper therapeutic dosage, an enhanced ability to treat difficult conditions, and ultimately better clinical outcomes.
EFFICACY REVIEW
The Mindray Resona 7 platform begins with proprietary and industry-first virtual beam-formation technology, ZONE Sonography® Technology+. The acquisition of larger and more robust acoustic data sets coupled with proprietary, industry-first virtual beamforming methods and innovative signal processing techniques translates into a number of unique imaging advantages. These include extremely fast image processing and display for noticeably improved temporal resolution; exceptional image uniformity throughout the field of view with improved spatial and contrast resolution. ZST+ also has the ability to generate novel and exclusive advanced diagnostic applications while improving the performance of established imaging technologies. Virtual beam formation will continue to shape the future of ultrasound imaging in impactful ways, allowing for more powerful technology, improved workflow tools, and the inclusion of more AI-based advancements. ZST+ has paved the way for the future of ultrasound.
SPECIAL THANKS
The producers of this exploratory performance test (HealthTech Reporter) wishes to thank Dr. Robert Bard for his innovative vision to convert his clinical diagnostic ultrasound imaging facility into a research validation lab for academic and scientific advancement of non-invasive technologies. Accordingly, we also express our deepest gratitude to Charles Vorwaller, CEO/Founder of Aspen Laser and Mark Murdoch (demo/training advisor) for their vast insight and technical participation and for the generous loan of the Apex Laser model. Further thanks goes to Michelle and Frank marcantonio of Mindray NA for their unending and gracious support and for the loan of the Mindray Resona 7- without whose help this study would not have been made possible.
No comments:
Post a Comment